North America

Europe, Middle East, and Africa

Asia-Pacific

Latin America

Total Revenue

6ef332725c251fc876e8115d9229f5a0f3b9b3c34b61b1310af96d8c69e2ad32

Current Assets

Cash and Cash Equivalents

Accounts Receivable

Inventory

Non-Current Assets

Property, Plant, and Equipment (PP&E)

Goodwill

Intangible Assets

Current Liabilities

Accounts Payable

Short-term Debt

Accrued Expenses

Non-Current Liabilities

Long-term Debt

Lease Liabilities

Deferred Tax Liabilities

Shareholders' Equity

Retained Earnings

Common Stock

Additional Paid-in Capital

e4e6c163c92759fe28860b1a2b5b580714f89dc66504ffb967962d4d1b3c9aaf

Total Revenue [USD, Millions]

Cost of Goods Sold (COGS) [USD, Millions]

SG&A [USD, Millions]

R&D [USD, Millions]

D&A [USD, Millions]

Interest Expense [USD, Millions]

Operating Income (EBIT) [USD, Millions]

Net Income [USD, Millions]

EPS - Basic [USD]

EPS - Diluted [USD]

eecfde06d85c8657d1d0ad546077a976f55674848910db2b7df54d4a2671cee2

Cash and cash equivalents (USD, millions)

Trade receivables, less allowances for credit losses (USD, millions)

Inventories (USD, millions)

Prepaid expenses and other receivables (USD, millions)

Other current assets (USD, millions)

Total current assets (USD, millions)

Property, plant, and equipment, net (USD, millions)

Intangible assets, net (USD, millions)

Goodwill (USD, millions)

Deferred taxes on income (USD, millions)

Other assets (USD, millions)

Total Assets (USD, millions)

Loans and notes payable (USD, millions)

Accounts payable (USD, millions)

Accrued liabilities (USD, millions)

Accrued rebates, returns, and promotions (USD, millions)

Accrued taxes on income (USD, millions)

Total current liabilities (USD, millions)

Employee-related obligations (USD, millions)

Long-term debt (USD, millions)

Other liabilities (USD, millions)

Total liabilities (USD, millions)

Preferred stock (USD, millions)

Common stock (USD, millions)

Additional paid-in capital (USD, millions)

Treasury stock (USD, millions)

Retained earnings (USD, millions)

Accumulated other comprehensive loss (USD, millions)

Total equity (USD, millions)

Total Liabilities and Equity (USD, millions)

bd2537ac0d9a0f60e7a90e67c46db977a5bdae7a3bbf0ca79c8cb153107ec26d

Net income (USD, millions)

Depreciation and amortization (USD, millions)

Stock-based compensation (USD, millions)

Deferred income taxes (USD, millions)

Impairment charges (USD, millions)

Other adjustments (USD, millions)

Net cash flows from operating activities (USD, millions)

Purchases of property, plant, and equipment (USD, millions)

Transfer of funds to J&J pursuant to the Facility Agreement (USD, millions)

Proceeds from J&J upon repayment of the Facility Agreement (USD, millions)

Proceeds from sale of assets (USD, millions)

Other investing activities (USD, millions)

Net cash flows used in investing activities (USD, millions)

Proceeds from (payments of) loans and notes payables (USD, millions)

Proceeds from Commercial Paper Program, net of issuance cost (USD, millions)

Proceeds from issuance of Senior Notes, net of issuance cost (USD, millions)

Proceeds from Kenvue IPO, net (USD, millions)

Distribution to J&J in connection with the Separation (USD, millions)

Dividends paid (USD, millions)

Net transfers to J&J (USD, millions)

Purchases of treasury shares (USD, millions)

Other financing activities (USD, millions)

Net cash flows used in financing activities (USD, millions)

Effect of exchange rate changes on cash and cash equivalents (USD, millions)

Net decrease/increase in cash and cash equivalents (USD, millions)

Trade receivables (USD, millions)

Other current and non-current assets (USD, millions)

Accounts payable and accrued liabilities (USD, millions)

Employee related obligations (USD, millions)

Cash and cash equivalents, beginning of period (USD, millions)

Cash and cash equivalents, end of period (USD, millions)

acd866f6072950f12be53999a8cb7663b7015d4577aff8e5476b310088e0ec78

Net sales (USD, millions)

Cost of sales (USD, millions)

Gross profit (USD, millions)

Selling, general, and administrative expenses (USD, millions)

Restructuring expenses (USD, millions)

Other operating expense (income), net (USD, millions)

Operating income (USD, millions)

Other (income) expense, net (USD, millions)

Interest expense, net (USD, millions)

Income before taxes (USD, millions)

Provision for taxes (USD, millions)

Net income per share Basic (USD)

Net income per share Diluted (USD)

Weighted average number of shares outstanding Basic (Millions)

Weighted average number of shares outstanding Diluted (Millions)

b57e618b1a95951ef676588ca713da08175b0d78d60970b84e9d834369124e9c

Adjustments for Non-Cash Items [USD, Millions]

Stock-Based Compensation [USD, Millions]

Changes in Working Capital [USD, Millions]

Capital Expenditures (CapEx) [USD, Millions]

Proceeds from / Repayments of Debt [USD, Millions]

Share Repurchases [USD, Millions]

Dividend Payments [USD, Millions]

Net Change in Cash [USD, Millions]

11ecc952873c796a25220c1bfef085200f10a81f71629b816f0d06221f307692

Self Care

Skin Health and Beauty

Essential Health

a0af6bc3f57264d2ce9b6e42fab36365b321a9b2ad17030c7566852bf8688f88

Kenvue Inc (KVUE)

Financials